|
|
|
Insider
Information: |
Boyd Steven |
Relationship: |
10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
18 |
|
Direct
Shares |
47,075,098 |
|
Indirect Shares
|
40,287,245 |
|
|
Direct
Value |
$128,455,406 |
|
|
Indirect Value
|
$40,265,984 |
|
|
Total
Shares |
87,362,343 |
|
|
Total
Value |
$168,721,391 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
99
|
96
|
Stock
price went up :
|
54
|
46
|
Stock
price went down : |
45
|
50
|
|
|
|
Gain/Loss Ratio : |
1.2
|
1.2
|
Percentage
Gain/Loss : |
-16.7%
|
8,928.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2023-06-27 |
34,370 |
2023-06-27 |
731,458 |
Premium* |
|
Dynatronics Corp |
DYNT |
10% Owner |
2017-03-21 |
500,000 |
2017-03-21 |
1,000,000 |
Premium* |
|
Kiora Pharmaceuticals |
KPRX |
10% Owner |
2021-01-06 |
3,346,601 |
2021-08-02 |
785,000 |
Premium* |
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
10% Owner |
2019-01-10 |
2,170,000 |
2019-01-10 |
2,170,000 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2018-02-06 |
6,936,000 |
2018-02-06 |
6,936,000 |
Premium* |
|
Cassava Sciences Inc |
SAVA |
10% Owner |
2018-10-03 |
1,651,340 |
2018-10-03 |
0 |
Premium* |
|
Del Friscos Restaurant Group, Llc |
DFRG |
10% Owner |
2019-09-25 |
0 |
2019-09-25 |
0 |
Premium* |
|
Valeritas Holdings Inc |
VLRX |
10% Owner |
2019-12-20 |
0 |
2019-12-20 |
0 |
Premium* |
|
Bio-Path Holdings, Inc. |
BPTH |
10% Owner |
2019-01-18 |
129,298 |
2019-01-18 |
129,298 |
Premium* |
|
AYTU BIOSCIENCE, INC |
AYTU |
Director |
2021-03-29 |
1,342,378 |
2021-03-29 |
1,342,378 |
Premium* |
|
Achieve Life Sciences Inc |
ACHV |
10% Owner |
2019-06-11 |
843,776 |
2019-06-11 |
843,776 |
Premium* |
|
AMAG Pharmaceuticals Inc |
AMAG |
10% Owner |
2020-03-16 |
4,120,000 |
2020-03-16 |
348,000 |
Premium* |
|
Onconova Therapeutics, Inc. |
ONTX |
10% Owner |
2019-09-23 |
816,702 |
2019-09-23 |
816,702 |
Premium* |
|
Vaxart Inc |
VXRT |
Director |
2020-06-29 |
145,523 |
2020-06-29 |
145,523 |
Premium* |
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director, 10% Owner |
2020-07-28 |
0 |
2020-07-28 |
0 |
Premium* |
|
Tenax Therapeutics Inc |
TENX |
Director, 10% Owner |
2020-09-08 |
2,019,995 |
2020-09-08 |
2,019,995 |
Premium* |
|
Cyclo Therapeutics, Inc |
CYTH |
10% Owner |
2020-09-30 |
15,795,769 |
2020-09-30 |
15,795,769 |
Premium* |
|
ReShape Lifesciences Inc |
RSLS |
10% Owner |
2021-06-28 |
7,223,346 |
2021-06-28 |
7,223,346 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
790 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 23 of 32
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TENX |
Tenax Therapeutics Inc |
Director |
|
2020-09-01 |
4 |
B |
$1.46 |
$43,800 |
D/D |
30,000 |
1,931,995 |
3.92 |
% |
|
TENX |
Tenax Therapeutics Inc |
Director |
|
2020-09-08 |
4 |
B |
$1.46 |
$12,473 |
D/D |
8,543 |
2,019,995 |
3.92 |
% |
|
TENX |
Tenax Therapeutics Inc |
10% Owner |
|
2020-08-24 |
4 |
B |
$1.47 |
$8,367 |
D/D |
5,692 |
1,840,784 |
2.37 |
% |
|
TENX |
Tenax Therapeutics Inc |
Director |
|
2020-09-02 |
4 |
B |
$1.47 |
$29,400 |
D/D |
20,000 |
1,951,995 |
3.92 |
% |
|
TENX |
Tenax Therapeutics Inc |
10% Owner |
|
2020-08-26 |
4 |
B |
$1.50 |
$18,000 |
D/D |
12,000 |
1,869,995 |
2.37 |
% |
|
TENX |
Tenax Therapeutics Inc |
Director |
|
2020-08-27 |
4 |
B |
$1.50 |
$18,000 |
D/D |
12,000 |
1,881,995 |
3.92 |
% |
|
TENX |
Tenax Therapeutics Inc |
Director |
|
2020-08-20 |
4 |
B |
$1.53 |
$190,442 |
D/D |
124,472 |
1,718,850 |
3.92 |
% |
|
TENX |
Tenax Therapeutics Inc |
10% Owner |
|
2020-08-25 |
4 |
B |
$1.53 |
$26,333 |
D/D |
17,211 |
1,857,995 |
2.37 |
% |
|
AYTU |
AYTU BIOSCIENCE, INC |
Director |
|
2020-04-27 |
4 |
S |
$1.82 |
$9,298,236 |
D/D |
(5,108,921) |
0 |
0 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2020-03-18 |
4 |
B |
$1.91 |
$54,307 |
I/I |
28,433 |
703,433 |
2.25 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2021-04-15 |
4 |
OE |
$2.00 |
$12,571,430 |
D/D |
6,285,715 |
38,920,000 |
0 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2020-03-17 |
4 |
B |
$2.05 |
$3,999,999 |
D/D |
1,951,219 |
28,160,605 |
3.92 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2021-05-14 |
4 |
B |
$2.15 |
$275,200 |
D/D |
128,000 |
39,048,000 |
3.92 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2020-04-03 |
4 |
B |
$2.16 |
$9,245 |
I/I |
4,280 |
832,194 |
2.17 |
% |
|
VLRX |
Valeritas Holdings Inc |
10% Owner |
|
2019-05-24 |
4 |
B |
$2.19 |
$8,760 |
D/D |
4,000 |
1,060,000 |
2.37 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2020-09-04 |
4 |
B |
$2.20 |
$220,000 |
D/D |
100,000 |
30,014,285 |
3.92 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2021-05-17 |
4 |
B |
$2.20 |
$66,000 |
D/D |
30,000 |
39,078,000 |
3.92 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2021-09-17 |
4 |
B |
$2.20 |
$11,999,999 |
I/I |
5,454,545 |
45,000,000 |
2.25 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2021-09-15 |
4 |
B |
$2.26 |
$215,948 |
I/I |
95,455 |
39,395,455 |
2.25 |
% |
|
VLRX |
Valeritas Holdings Inc |
10% Owner |
|
2019-05-23 |
4 |
B |
$2.28 |
$45,600 |
D/D |
20,000 |
1,056,000 |
2.37 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2021-09-16 |
4 |
B |
$2.28 |
$341,955 |
I/I |
150,000 |
39,545,455 |
2.25 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2020-11-23 |
4 |
B |
$2.32 |
$86,459 |
D/D |
37,267 |
30,051,552 |
3.92 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2020-03-31 |
4 |
B |
$2.33 |
$62,004 |
I/I |
26,611 |
827,914 |
2.25 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2021-05-18 |
4 |
B |
$2.33 |
$51,260 |
D/D |
22,000 |
39,100,000 |
3.92 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2020-03-30 |
4 |
B |
$2.35 |
$115,862 |
I/I |
49,303 |
801,303 |
2.25 |
% |
|
790 Records found
|
|
Page 23 of 32 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|